Anticancer Res

1. AOYAMA T, Hashimoto I, Maezawa Y, Hara K, et al
   Clinical Impact of the Lymphocyte-to-Monocyte Ratio in Patients With Gastric Cancer who Received Curative Treatment.
   Anticancer Res. 2024;44:1567-1574.
   

   >> Share

   
   
2. HWANG SH, Kim DJ
   Nomogram for Predicting Infectious Complications Following Curative Gastrectomy Using Clinical and Laboratory Parameters.
   Anticancer Res. 2024;44:1781-1790.
   

   >> Share

   
   
3. NUMAKURA S, Uozaki H
   Gastric Cancer With the Increased Nicotinamide N-methyltransferase-positive Stromal Cells Includes Unfavorable Prognosis-related Cancer-associated Fibroblasts.
   Anticancer Res. 2024;44:1653-1660.
   

   >> Share

   
   
4. MORINO K, Yamamoto M, Shimoike N, Iwasaki Y, et al
   Safety and Limitations of Laparoscopic Total Gastrectomy for Gastric Cancer: A Comparative Analysis of Short and Long-term Outcomes With Open Surgery.
   Anticancer Res. 2024;44:1759-1766.
   

   >> Share

   
   
5. AOYAMA T, Maezawa Y, Hashimoto I, Hara K, et al
   The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.
   Anticancer Res. 2024;44:1629-1636.
   

   >> Share

   
   
6. AGATSUMA Y, Nakanishi K, Tanaka C, Kanda M, et al
   Risk Factors for Long-term Body Weight Loss After Proximal Gastrectomy: A Retrospective Analysis.
   Anticancer Res. 2024;44:1645-1651.
   

   >> Share

   
   
7. CHEN G, Shang J, Feng X, Li M, et al
   Hsa_circTCF25 Facilitates Oncogenesis in Gastric Cancer Cells by Modulating miR-149 Expression.
   Anticancer Res. 2024;44:1475-1485.
   

   >> Share

   
   

   
   BMC Cancer

8. TAN Y, Feng LJ, Huang YH, Xue JW, et al
   Development and validation of a Radiopathomics model based on CT scans and whole slide images for discriminating between Stage I-II and Stage III gastric cancer.
   BMC Cancer. 2024;24:368.
   

   >> Share

   
   
9. YOON C, Lu J, Jun Y, Suh YS, et al
   Retraction Note: KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis.
   BMC Cancer. 2024;24:392.
   

   >> Share

   
   

   
   Cancer Lett

10. ZHAO Z, Cai Z, Zhang S, Yin X, et al
    Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer.
    Cancer Lett. 2024 Mar 25:216796. doi: 10.1016/j.canlet.2024.216796.
    

    >> Share

    
    

    
    Dig Dis Sci

11. HIGUCHI K, Goto O, Matsuda A, Nakagome S, et al
    Potential of Direct Oral Anticoagulant in Bleeding After Gastric Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2024;69:940-948.
    

    >> Share

    
    

    
    Eur J Surg Oncol

12. NOOR Z, Gossage J, Evans O, Cuffe R, et al
    Unmet needs in survivorship: Increased anxiety post oesophago-gastric cancer surgery.
    Eur J Surg Oncol. 2024;50:108046.
    

    >> Share

    
    
13. HUANG ZN, Zheng CY, Wu J, Tang YH, et al
    Textbook oncological outcomes and prognosis after curative gastrectomy in advanced gastric cancer: A multicenter study.
    Eur J Surg Oncol. 2024;50:108280.
    

    >> Share

    
    
14. VAN DER SLUIS K, Guchelaar NAD, Triemstra L, Mathijssen RHJ, et al
    Staging laparoscopy in gastric cancer patients: From a Dutch nationwide Delphi consensus towards a standardized protocol.
    Eur J Surg Oncol. 2024;50:108278.
    

    >> Share

    
    

    
    Gastroenterology

15. AIHARA H, Draganov PV
    Does a Rising Tide Lift All Boats? How Institutional Procedural Volume Impacts the Clinical Outcomes of Gastric Endoscopic Submucosal Dissection.
    Gastroenterology. 2024;166:561-563.
    

    >> Share

    
    
16. PARK JY, Kim MS, Kim BJ, Kim JG, et al
    Influence of Procedural Volume on the Outcome of Gastric Endoscopic Submucosal Dissection: A Nationwide Population-Based Study Using Administrative Data.
    Gastroenterology. 2024;166:680-689.
    

    >> Share

    
    
17. CHEN YY, Chang HM, Chen CH
    A Rare Cause of Duodenal ulcer.
    Gastroenterology. 2023 Nov 8:S0016-5085(23)05225.
    

    >> Share

    
    

    
    J Cancer Res Clin Oncol

18. PENG H, Wu X, Zhang C, Liang Y, et al
    Analyzing the associations between tertiary lymphoid structures and postoperative prognosis, along with immunotherapy response in gastric cancer: findings from pooled cohort studies.
    J Cancer Res Clin Oncol. 2024;150:153.
    

    >> Share

    
    
19. LI F, Wen Z
    Identification roles of NFE2L3 in digestive system cancers.
    J Cancer Res Clin Oncol. 2024;150:150.
    

    >> Share

    
    

    
    Surgery

20. THONG DQ, Le Minh Quoc H, Dat TQ, Hai NV, et al
    Billroth-II modified with hinged anti-peristaltic afferent loop versus Roux-en-Y reconstruction after distal gastrectomy for gastric cancer: A propensity-score match analysis.
    Surgery. 2024 Mar 26:S0039-6060(24)00076-X. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share